Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats

Detalhes bibliográficos
Autor(a) principal: Roşca,A.E.
Data de Publicação: 2016
Outros Autores: Stoian,I., Badiu,C., Gaman,L., Popescu,B.O., Iosif,L., Mirica,R., Tivig,I.C., Stancu,C.S., Căruntu,C., Voiculescu,S.E., Zăgrean,L.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600706
Resumo: Supraphysiological administration of anabolic androgenic steroids has been linked to increased blood pressure. The widely distributed amino acid taurine seems to be an effective depressor agent in drug-induced hypertension. The purpose of this study was to assess the impact of chronic high dose administration of nandrolone decanoate (DECA) and taurine on blood pressure in rats and to verify the potentially involved mechanisms. The study was conducted in 4 groups of 8 adult male Wistar rats, aged 14 weeks, treated for 12 weeks with: DECA (A group); vehicle (C group); taurine (T group), or with both drugs (AT group). Systolic blood pressure (SBP) was measured at the beginning of the study (SBP1), 2 (SBP2) and 3 months (SBP3) later. Plasma angiotensin-converting enzyme (ACE) activity and plasma end products of nitric oxide metabolism (NOx) were also determined. SBP3 and SBP2 were significantly increased compared to SBP1 only in the A group (P<0.002 for both). SBP2, SBP3 and ACE activity showed a statistically significant increase in the A vs C (P<0.005), andvs AT groups (P<0.05), while NOx was significantly decreased in the A and AT groups vs controls (P=0.01). ACE activity was strongly correlated with SBP3 in the A group (r=0.71, P=0.04). These findings suggest that oral supplementation of taurine may prevent the increase in SBP induced by DECA, an effect potentially mediated by angiotensin-converting enzyme.
id ABDC-1_b4ad584f4bfd92c77b38aedbd8019daa
oai_identifier_str oai:scielo:S0100-879X2016000600706
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in ratsAnabolic androgenic steroidsNandrolone decanoateTaurineBlood pressureAngiotensin-converting enzymeNitric oxideSupraphysiological administration of anabolic androgenic steroids has been linked to increased blood pressure. The widely distributed amino acid taurine seems to be an effective depressor agent in drug-induced hypertension. The purpose of this study was to assess the impact of chronic high dose administration of nandrolone decanoate (DECA) and taurine on blood pressure in rats and to verify the potentially involved mechanisms. The study was conducted in 4 groups of 8 adult male Wistar rats, aged 14 weeks, treated for 12 weeks with: DECA (A group); vehicle (C group); taurine (T group), or with both drugs (AT group). Systolic blood pressure (SBP) was measured at the beginning of the study (SBP1), 2 (SBP2) and 3 months (SBP3) later. Plasma angiotensin-converting enzyme (ACE) activity and plasma end products of nitric oxide metabolism (NOx) were also determined. SBP3 and SBP2 were significantly increased compared to SBP1 only in the A group (P<0.002 for both). SBP2, SBP3 and ACE activity showed a statistically significant increase in the A vs C (P<0.005), andvs AT groups (P<0.05), while NOx was significantly decreased in the A and AT groups vs controls (P=0.01). ACE activity was strongly correlated with SBP3 in the A group (r=0.71, P=0.04). These findings suggest that oral supplementation of taurine may prevent the increase in SBP induced by DECA, an effect potentially mediated by angiotensin-converting enzyme.Associação Brasileira de Divulgação Científica2016-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600706Brazilian Journal of Medical and Biological Research v.49 n.6 2016reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431x20165116info:eu-repo/semantics/openAccessRoşca,A.E.Stoian,I.Badiu,C.Gaman,L.Popescu,B.O.Iosif,L.Mirica,R.Tivig,I.C.Stancu,C.S.Căruntu,C.Voiculescu,S.E.Zăgrean,L.eng2019-03-25T00:00:00Zoai:scielo:S0100-879X2016000600706Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2019-03-25T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats
title Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats
spellingShingle Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats
Roşca,A.E.
Anabolic androgenic steroids
Nandrolone decanoate
Taurine
Blood pressure
Angiotensin-converting enzyme
Nitric oxide
title_short Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats
title_full Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats
title_fullStr Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats
title_full_unstemmed Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats
title_sort Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats
author Roşca,A.E.
author_facet Roşca,A.E.
Stoian,I.
Badiu,C.
Gaman,L.
Popescu,B.O.
Iosif,L.
Mirica,R.
Tivig,I.C.
Stancu,C.S.
Căruntu,C.
Voiculescu,S.E.
Zăgrean,L.
author_role author
author2 Stoian,I.
Badiu,C.
Gaman,L.
Popescu,B.O.
Iosif,L.
Mirica,R.
Tivig,I.C.
Stancu,C.S.
Căruntu,C.
Voiculescu,S.E.
Zăgrean,L.
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Roşca,A.E.
Stoian,I.
Badiu,C.
Gaman,L.
Popescu,B.O.
Iosif,L.
Mirica,R.
Tivig,I.C.
Stancu,C.S.
Căruntu,C.
Voiculescu,S.E.
Zăgrean,L.
dc.subject.por.fl_str_mv Anabolic androgenic steroids
Nandrolone decanoate
Taurine
Blood pressure
Angiotensin-converting enzyme
Nitric oxide
topic Anabolic androgenic steroids
Nandrolone decanoate
Taurine
Blood pressure
Angiotensin-converting enzyme
Nitric oxide
description Supraphysiological administration of anabolic androgenic steroids has been linked to increased blood pressure. The widely distributed amino acid taurine seems to be an effective depressor agent in drug-induced hypertension. The purpose of this study was to assess the impact of chronic high dose administration of nandrolone decanoate (DECA) and taurine on blood pressure in rats and to verify the potentially involved mechanisms. The study was conducted in 4 groups of 8 adult male Wistar rats, aged 14 weeks, treated for 12 weeks with: DECA (A group); vehicle (C group); taurine (T group), or with both drugs (AT group). Systolic blood pressure (SBP) was measured at the beginning of the study (SBP1), 2 (SBP2) and 3 months (SBP3) later. Plasma angiotensin-converting enzyme (ACE) activity and plasma end products of nitric oxide metabolism (NOx) were also determined. SBP3 and SBP2 were significantly increased compared to SBP1 only in the A group (P<0.002 for both). SBP2, SBP3 and ACE activity showed a statistically significant increase in the A vs C (P<0.005), andvs AT groups (P<0.05), while NOx was significantly decreased in the A and AT groups vs controls (P=0.01). ACE activity was strongly correlated with SBP3 in the A group (r=0.71, P=0.04). These findings suggest that oral supplementation of taurine may prevent the increase in SBP induced by DECA, an effect potentially mediated by angiotensin-converting enzyme.
publishDate 2016
dc.date.none.fl_str_mv 2016-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600706
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600706
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1414-431x20165116
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.49 n.6 2016
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302945020608512